Erectile Dysfunction
Recovery

Bioelectric Signaling designed for
Erectile Dysfunction Recovery

Our precision signals are directed
towards controlling the release
of these natural proteins.

Erectile Dysfunction
Recovery

Bioelectric Signaling designed for
Erectile Dysfunction Recovery

Our precision signals are directed
towards controlling the release
of these natural proteins.
According to landmark studies by University of Chicago researchers, among men aged 50 to 64, about one-third suffer erectile dysfunction otherwise known as ED. From age 65 to 85, the figure is approximately 44 percent.

ErectiStim has developed a patent pending technology of precise bioelectric signaling designed for erectile dysfunction recovery. Our precision signals are directed towards controlling the release of these natural proteins.

SDF-1 & PDGF for stem cell homing

IGF-1 & LIM for Nerve Regeneration

Follistatin & Klotho for muscle regeneration

EGF for Metabolic Syndrome Reversal

VEGF, PDGF, EGF, HIF1a, CXCL5, eNos and SDF1

for improving blood circulation

An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled trial

MyoStim ED ErectiStim Endorses the SMSNA Position on Regulatory Pathway for Restorative Therapies for ED

ErectiStim Plus Lite™ MyoStim ED Biologics Clinical Study Protocol

Important Papers

Click to download

MyoStim ED ErectiStimTM Bench Top Clinic Use High Fidelity
Precision Signal Stimulator

(U.S. FDA 510K K113017 cleared only for improving blood circulation, improved range of motion muscle
other labelling claims pending new 510K submission with new data)

MyoStim ED ErectiStim
at home use portable bioelectric stimulator

(not available for sale investigational use only)

The goal of ErectiStim is to end dependence on shots and pills and to affect a recovery of erectile function equivalent to what the men had in their 30’s or early 40’s.

The therapy is delivered via a comfortable conductive wrap with bioelectric stimulation delivered as little a 7 to 20 minutes every other day for 12 weeks run from the comfort of your own home.

Cristiane Carboni

Chief Scientific Officer
MyoStim ED ErectiStim

An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled trial

Worldwide more than 330 million of men suffer from ED.

German data: 19% of men are affected*
2% (aged 30 – 39 years)
10% (aged 40 – 49 years)
16% (aged 50 – 59 years)
34% (aged 60 – 69 years)
53% (aged 70 – 79 years)
*Braun et.al.
Epidemiology of erectile dysfunction: results of the Cologne Male Survey.
In: Int J Impot Res
12 (2000), Nr. 6, S. 305–11
Investigational Use Only at this time. Not available for sale. Statistically significant clinical trials have yet to be completed to prove safety or efficacy definitively.
CAUTION Disclaimer and Warning: Products described on this web site are in early stage development and are not yet proven safe or effective in statistically significant controlled clinical studies. Any statement or phrases implying efficacy or safety in any form are considered modified by “intended to” or “designed to”. Investigational use only in countries where investigation is permitted by law and proper filings have been made and appropriate regulatory clearances have been granted. Any use of the product(s) must be in an authorized clinical study with institutional review board (ethics committee) approval and proper patient consent procedures followed. For other countries product is only available for laboratory investigation by credentialed institutions and investigators with proper clearances with a research agreement in place with a study sponsor. NOT AVAILABLE FOR SALE.